Navigation Links
Solos Endoscopy Reports Full Year 2012 Results
Date:5/15/2013

BOSTON, May 15, 2013 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, reported sales and earnings results for the full year ended December 31, 2012.

In addition, the Company's President, Robert Segersten , posted a Letter to Shareholders outlining recent announcements and updates on the Company's progress as it relates to its product lines and pursuit of ISO 13485 certification and CE Mark for its MammoView® devices.

The Company's financial results, disclosure statement and President's Letter can be found on the OTC Markets website (http://www.otcmarkets.com/stock/SNDY/financials).

About Solos Endoscopy, Inc.:

Solos Endoscopy is celebrating its 25th Year of providing quality innovative healthcare instruments to Hospitals across the Country. For more than 25 Years, from medical schools to hospitals, surgeons have trusted Solos Endoscopy to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.

For more information on TUV SUD America visit www.tuvamerica.com

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Annual Report filing and other filings with the OTC Markets Group (available at www.otcmarkets.com). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

Source: Solos Endoscopy, Inc.
Investor Relations
(617) 360-9719


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy Reduces Liabilities by More than $570,000
2. Solos Endoscopys Bariatric Instruments Are Now Available
3. Solos Endoscopy Posts Total Assets of $2,426,883 for Period Ended June 30, 2012
4. Solos Endoscopy Sales Increase by More than 35% for the Month of October
5. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
6. Solos Endoscopy and TUV SUD America Schedule Stage 1 ISO 13485 Audit for February 26, 2013
7. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
8. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
9. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
10. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
11. Asia Pacific Endoscopy Devices Industry is Expected to Reach USD 3.4 Billion in 2017: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of ... News website. , Rod has been at the forefront of Gardant since it was ... CEO, Rod has overseen the opening of more than 40 new senior living communities. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May ... for an educational and exciting 2-day program. , An attendee at a recent ... they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient ...
(Date:4/24/2017)... New York, NY (PRWEB) , ... April 24, ... ... students in 72 countries clearly shows that over the last decade, student well-being ... have ticked all the boxes of formal education, join the Islamic State to ...
(Date:4/24/2017)... ... 24, 2017 , ... “The Saint with Trin, and Omega Station”: a triple ... the creation of published author, Chris Jackson. Chris Jackson grew up in Abilene, ... Dallas Independent School District teaching English. He is heavily involved in the youth group ...
(Date:4/24/2017)... NC and Seattle, WA (PRWEB) , ... April ... ... utilized by 75+ leading lifestyle brands, work wear distributors and International relief organizations ... they can carry. The company also offers lifestyle and work wear collections via ...
Breaking Medicine News(10 mins):